Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Guidance On Electronic Clinical Trial Data Slated For Late August

Executive Summary

FDA plans to publish a draft guidance on the use of computerized systems in clinical trials by the end of August

You may also be interested in...



Clinical Trials Computerized Systems Guidance Issued; GSK Sees Savings

GlaxoSmithKline expects significant savings through the elimination of data managers as the company moves to computerize its clinical trial data, the company said

Clinical Trials Computerized Systems Guidance Issued; GSK Sees Savings

GlaxoSmithKline expects significant savings through the elimination of data managers as the company moves to computerize its clinical trial data, the company said

NDA Reviews Will Be Risk-Based Under FDA Good Manufacturing Initiative

The Center for Drug Evaluation & Research will apply a risk-based approach in considering manufacturing issues in reviewing NDAs, Office of Compliance Director David Horowitz said

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044541

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel